Anxiolytic‐Like Effects of Various Selective Serotonin Reuptake Inhibitors and Serotonin‐Noradrenaline Reuptake Inhibitors in Zebrafish
Neuropsychopharmacology Reports · 2026-12 · 46 (4)
DOI: 10.1002/npr2.70178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 16.11.2026. Verfasst von Kanon Shinokawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Anti-Anxiety Agents, Serotonin and Noradrenaline Reuptake Inhibitors, Anxiety. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI, Takeda Science Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
SSRIs and SNRIs have been recognized as the primary therapeutic interventions for anxiety disorders. Although numerous SSRIs and SNRIs are available and often considered equally effective, objective differences in their anxiolytic effects and underlying mechanisms remain unclear. In this study, four major SSRIs and SNRIs—sertraline (SER), escitalopram (ESC), duloxetine (DUL), and venlafaxine (VEN)—were selected and their anxiolytic‐like effects were evaluated in zebrafish using the novel tank test. The biological mechanism underlying the anxiolytic‐like effects was also examined. The present study was predicated on the evaluation of monoamine receptor and transporter gene expression levels. The results demonstrated that SER showed a trend toward increased exploratory behavior and significantly decreased freezing duration, exhibiting the most stable anxiolytic‐like profile, followed by ESC. The administration of DUL was primarily associated with a trend toward increased erratic movements rather than clear anxiolysis. Meanwhile, VEN did not demonstrate a substantial difference from the control group. These distinct behavioral profiles may be attributable not only to increased serotonin activity but also to distinct dopamine activity and associated transcriptional alterations. Further studies are needed to elucidate the biological mechanisms of the anxiolytic effects of each antidepressant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
- Center for the Promotion of Interdisciplinary Research in Medicine and Life Science, Keio University School of Medicine, Tokyo, Japan.
- Fujisawa Hospital, Fujisawa, Kanagawa, Japan.
- Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
ORCID-Profile: Kanon Shinokawa, Saki Hattori, Masatoshi Miyauchi, Nobuhiko Noguchi, Akira Suda
Förderung
- Japan Society for the Promotion of Science (JSPS) KAKENHI
- Takeda Science Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Shinokawa, K., Hattori, S., Miyauchi, M., Noguchi, N., Eto, Y., Suda, A., Kishida, I., Hishimoto, A., & Asami, T. (2026). Anxiolytic‐Like Effects of Various Selective Serotonin Reuptake Inhibitors and Serotonin‐Noradrenaline Reuptake Inhibitors in Zebrafish. Neuropsychopharmacology Reports, 46(4). https://doi.org/10.1002/npr2.70178
Vancouver
Shinokawa K, Hattori S, Miyauchi M, Noguchi N, Eto Y, Suda A, et al. Anxiolytic‐Like Effects of Various Selective Serotonin Reuptake Inhibitors and Serotonin‐Noradrenaline Reuptake Inhibitors in Zebrafish. Neuropsychopharmacology Reports. 2026;46(4). doi:10.1002/npr2.70178
BibTeX
@article{Shinokawa2026,
author = {Shinokawa, Kanon and Hattori, Saki and Miyauchi, Masatoshi and Noguchi, Nobuhiko and Eto, Yuma and Suda, Akira and Kishida, Ikuko and Hishimoto, Akitoyo and Asami, Takeshi},
title = {Anxiolytic‐Like Effects of Various Selective Serotonin Reuptake Inhibitors and Serotonin‐Noradrenaline Reuptake Inhibitors in Zebrafish},
journal = {Neuropsychopharmacology Reports},
year = {2026},
volume = {46},
number = {4},
doi = {10.1002/npr2.70178}
}
EUVIMED